TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
The report provides comprehensive information on the therapeutics under development by Anacor Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Read More At: http://www.researchbeam.com/anacor-pharmaceuticals-inc-productpipeline-review-2016-market
Scope
• The report provides a snapshot of the pipeline therapeutic landscape of Anacor Pharmaceuticals, Inc. • The report provides overview of Anacor Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
Reasons to buy
• Evaluate Anacor Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies • Identify potential new clients or partners in the target demographic • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Read More At: http://www.researchbeam.com/anacor-pharmaceuticals-inc-productpipeline-review-2016-market
List of Tables
Anacor Pharmaceuticals, Inc., Key Information 6 Anacor Pharmaceuticals, Inc., Key Facts 6 Anacor Pharmaceuticals, Inc. - Pipeline by Indication, 2016 8 Anacor Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016 10 Anacor Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016 11 Anacor Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016 12 Anacor Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016 13 Anacor Pharmaceuticals, Inc. - Pre-Registration, 2016 14 Anacor Pharmaceuticals, Inc. - Phase II, 2016 15 Anacor Pharmaceuticals, Inc. - Phase I, 2016 16 Anacor Pharmaceuticals, Inc. - Preclinical, 2016 17 Anacor Pharmaceuticals, Inc. - Discovery, 2016 18 Anacor Pharmaceuticals, Inc. - Pipeline by Target, 2016 36 Anacor Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016 37 Anacor Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016 38 Anacor Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Enquire More At: http://www.researchbeam.com/anacor-pharmaceuticals-inc-productpipeline-review-2016-market/enquire-about-report
Visit us at http://www.researchbeam.com/anacor-pharmaceuticals-incproduct-pipeline-review-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States